# FDA Inspection 1199416 - Vitalant - February 07, 2023

Source: https://www.keypedia.com/records/fda_inspections/vitalant/73a0856e-c1d2-4cc2-b44e-aec130d1fd40
Source feed: FDA_Inspections

> FDA Inspection 1199416 for Vitalant on February 07, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1199416
- Company Name: Vitalant
- Inspection Date: 2023-02-07
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1199416 - 2023-02-07](https://www.keypedia.com/records/fda_inspections/vitalant/a1acef38-4e76-439f-8ae1-38dc96d46399)
- [FDA Inspection 1078439 - 2018-11-27](https://www.keypedia.com/records/fda_inspections/vitalant/d50084fa-332f-44d1-8477-415733af19b8)
- [FDA Inspection 1020017 - 2017-06-21](https://www.keypedia.com/records/fda_inspections/vitalant/4dc43ae6-b362-4d13-9e8a-ace2509892c0)
- [FDA Inspection 951010 - 2015-11-24](https://www.keypedia.com/records/fda_inspections/vitalant/fbb9d2f2-cf57-436e-b43b-18a683f80c6b)
- [FDA Inspection 798352 - 2012-09-12](https://www.keypedia.com/records/fda_inspections/vitalant/73687adf-5dbe-489f-bc7d-39f0869875fe)

Company: https://www.keypedia.com/companies/vitalant/520c0904-55f9-4f5a-9228-eeeca4ef50ad

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d